FDA inspection
AbbVie Deutschland GmbH & Co. KG: FDA inspection ending May 16, 2025
FDA inspection 1272781 · No Action Indicated (NAI) · Ludwigshafen
Key facts
| Inspection ID | 1272781 |
|---|---|
| Firm | AbbVie Deutschland GmbH & Co. KG |
| FEI number | 3002807401 |
| Address | Knollstrasse |
| City | Ludwigshafen |
| Country | Germany |
| Fiscal year | 2025 |
| Inspection end date | May 16, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data